Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ekso Bionics Holdings (EKSO) Net Margin (2016 - 2025)

Ekso Bionics Holdings (EKSO) has disclosed Net Margin for 13 consecutive years, with 148.54% as the latest value for Q4 2025.

  • On a quarterly basis, Net Margin fell 8148.0% to 148.54% in Q4 2025 year-over-year; TTM through Dec 2025 was 106.53%, a 4332.0% decrease, with the full-year FY2025 number at 106.53%, down 4332.0% from a year prior.
  • Net Margin was 148.54% for Q4 2025 at Ekso Bionics Holdings, down from 33.59% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 33.59% in Q3 2025 to a low of 196.35% in Q2 2025.
  • A 5-year average of 105.6% and a median of 97.87% in 2022 define the central range for Net Margin.
  • Peak YoY movement for Net Margin: surged 16352bps in 2021, then plummeted -14755bps in 2025.
  • Ekso Bionics Holdings' Net Margin stood at 92.26% in 2021, then plummeted by -37bps to 126.78% in 2022, then skyrocketed by 48bps to 66.31% in 2023, then dropped by -1bps to 67.05% in 2024, then plummeted by -122bps to 148.54% in 2025.
  • Per Business Quant, the three most recent readings for EKSO's Net Margin are 148.54% (Q4 2025), 33.59% (Q3 2025), and 196.35% (Q2 2025).